Dr. Ahmed Farhan
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD of simple fatty liver, is a liver condition where the liver starts to accumulate excess fat around its tissues.
It is the most common chronic liver condition that affects almost 25% to 40% of the adult population worldwide.
Fatty liver disease is quiet and asymptomatic, as the liver has the least nerve endings for pain reception.
So, mostly fat accumulation and inflammation in the liver go unnoticed. The individuals suffering from fatty liver have no physical impact on their day-to-day life, so this is majorly treated as a minor public health concern,n though studies suggest that it is the progression from simple hepatic steatosis to life-threatening hepatic and extrahepatic complications.
Understanding the phenotypes of fatty liver disease:
For a broader spectrum of this disease to understand, we have to look at the phenotypes of MASLD, as it is not a simple diagnosis; it is widely composed of two phenotypes.
● MASLD: formerly known as NAF, L, also known as simple steatosis. This is the baseline accumulation of excessive f within the liver tissues.
At this specific time,e there is no significant inflammation and cellular damage in the liver. But it serves as a foundation to underline issues regarding liver-related mortality and morbidity.
● MASH: formerly known as NASH. This is the active progressive form of fatty liver disease. In this scenario, the accumulated liver fat leads to high metabolic stress, which can stimulate lipotoxicity,y which eventually could cause chronic tissue inflammation and cellular death within the liver tissues.
Intrahepatic complications of fatty liver disease:
When fatty liver disease progresses, the simple accumulation of fat cells turns into widespread liver damage. If untreated, fatty liver progresses into a predictable four-stage development of liver damage.
● Simple steatosis: (NAFL or MASL) liver accumulates lipid molecules within the liver cells while retaining its cell structure and its filtration capabilities are uncompromised.
● Steatohepatitis: as lipotoxicity increases, the fat droplets deliberately cause an aggressive immune reaction. Immune cells infiltrate the liver tissues and cause ultimate cell death, resulting in persistent inflammation.
● Liver fibrosis: the regenerative properties of the liver in genuine desperation of repairing the tissues cause deposition of excess extracellular protein called scar tissue.
The expansion of scar tissues causes severe stiffening and blood flow hindrance, thus resulting in loss of regeneration abilities.
● Cirrhosis: this is the final stage of liver scarring and is often irreversible. The extensive bands of scar tissue completely restructure the liver anatomy.
The liver shrinks, hardens, and begins to fail. Cirrhosis often comprises life-threatening events like ascites (fluid begins to accumulate in the abdominal cavity), hepatic encephalopathy ( cognitive decline, including confusion, lethargy, and altered consciousness due to an excess of toxins in the bloodstream as the liver fails to filter them), and esophageal varices (enlarged, brittle veins in the esophagus that can rupture at any time, causing internal bleeding.
● Risk of HCC: aside from this liver damage process, untreated fatty liver disease, when reaching the cirrhosis level, can spike the risk of primary liver cancer,r hepatocellular carcinoma (HCC).
The continuous cycle of cellular destruction, inflammation, and hyperregeneration can lead to the development of genetic mutations. These mutated cells can form aggressive malignant tumors. Untreated fatty liver disease has rapidly emerged as one of the causes of HCC worldwide.
Extrahepatic complications:
The extrahepatic complications of untreated fatty liver can never be overlooked, as it is the systemic metabolic crisis of the human body closely related to obesity, high blood pressure, and dyslipidemia. Clinical evidence revealed that an untreated fatty liver acts as a precursor for severe diseases in major organ systems.
● CVD: a majority of the population with fatty liver disease don’t die from liver failure, but the leading cause of fattyliver-relatedd death is cardiovascular diseases.
Untreated fatty liver releases cytokines and thrombotic factors into the general circulation. This ongoing systemic inflammation accelerates the process of atherosclerosis. Major cardiovascular events are associated with untreated MASLD i, including heart attacks and strokes.
● Type 2 diabetes mellitus: MASLD and insulin resistance have a very vicious reciprocal relationship. When the liver accumulates lipid droplets, it becomes insensitive to insulin, a hormone responsible for managing blood sugar.
This resistance causes the pancreas to release more insulin. More insulin production signals the body to store more fats in the liver.
Which eventually leads to type 2 diabetes mellitus. Clinical data suggest an increased risk of developing T2DM.
● CKD: the systemic damage associated with unmanaged fatty liver is not limited to CVS; it extends directly to the renal system as well.
The inflammation and oxidative stress caused by fatty liver are shared with CKD progression as they directly damage the filtration units of the kidneys, potentially causing renal failure at the very least.
The hope of reversibility:
In its early stages (MASL and early MASH, fatty liver disease is highly reversible. Due to the remarkable regenerative abilities of the liver, targeted dietary and lifestyle interventions can stop inflammatory damage and subsequently decrease lipid accumulation within the liver cells before permanent scar tissue forms.
● Weight management: losing around 7 to 10 percent of the total body weight has been clinically linked with reducing liver inflammation and can reverse early fibrosis.
● Dietary restrictions: moving away from highly processed carbs and trans fats while adopting a nutrient-dense diet rich in antioxidants helps stabilize the liver metabolic pathways,
● Physical activity: regular aerobic and resistance training exercises help improve systemic insulin resistance, causing the body to use fat reserves trapped inside liver tissues for energy.
Conclusion:
Leaving fatty liver disease untreated is a gamble with systemic health. What begins as a silent compilation of fat molecules can quietly evolve into fatal liver complications involving liver cirrhosis, liver cancer, catastrophic cardiovascular events, type 2 diabetes, and chronic kidney disease.
Because you cannot rely on physical symptoms or standard liver enzyme tests to warn you of the danger of fatty liver disease, awareness and early preventive action are your absolute best lines of defense.
If you live with metabolic risk factors, talk to your healthcare team about proactive liver health assessments today. Protecting your liver now prevents a cascade of life-altering complications tomorrow.
